COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Historical Holders from Q2 2015 to Q3 2025

Symbol
COLL on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
31,604,526
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
36,952,723
Holdings value
$1,292,788,238
% of all portfolios
0.001%
Number of holders
240
Number of buys
125
Number of sells
-110
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.6% $133,841,807 4,997,827 BlackRock, Inc. 31 Mar 2025
Rubric Capital Management LP 9.34% +29.3% $80,340,000 +$17,407,000 3,000,000 +27.7% Rubric Capital Management LP 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC 5.06% +4.8% $55,955,623 +$2,729,885 1,599,189 +5.1% Renaissance Technologies LLC 08 Sep 2025
Invesco Ltd. 4.9% -10% $48,100,835 -$5,793,481 1,584,871 -10.7% Invesco Ltd. 30 Jun 2025
PRINCIPAL GLOBAL INVESTORS 4.6% $44,508,457 1,466,506 PRINCIPAL GLOBAL INVESTORS 30 Jun 2025
Pacer Advisors, Inc. 1.06% -86.8% $11,222,855 -$46,153,054 419,076 -80.4% Pacer Advisors, Inc. 31 Mar 2025

Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 36,952,723 $1,292,788,238 +$41,295,458 $34.99 240
2025 Q2 35,739,346 $1,056,745,851 -$27,671,390 $29.57 221
2025 Q1 36,773,847 $1,097,284,609 -$11,471,996 $29.85 241
2024 Q4 37,138,457 $1,064,290,472 -$54,467,577 $28.65 238
2024 Q3 38,489,790 $1,486,827,407 -$25,778,054 $38.64 248
2024 Q2 39,660,571 $1,277,281,895 -$10,053,520 $32.2 229
2024 Q1 39,565,870 $1,535,798,999 +$15,800,408 $38.82 226
2023 Q4 39,202,475 $1,206,720,767 +$15,870,252 $30.78 190
2023 Q3 38,712,156 $865,246,259 -$10,117,275 $22.35 174
2023 Q2 39,246,501 $843,481,973 +$2,463,793 $21.49 177
2023 Q1 39,049,844 $936,805,999 +$74,091,480 $23.99 196
2022 Q4 36,094,328 $837,390,551 +$6,535,089 $23.2 174
2022 Q3 35,876,068 $574,780,379 -$19,538,698 $16.02 158
2022 Q2 36,430,591 $645,532,750 +$14,193,849 $17.72 152
2022 Q1 36,080,262 $733,927,682 +$6,776,837 $20.36 161
2021 Q4 35,805,022 $668,826,744 -$13,881,763 $18.68 152
2021 Q3 36,444,427 $719,484,752 -$39,361,775 $19.74 150
2021 Q2 37,987,862 $898,085,585 -$27,328 $23.64 155
2021 Q1 38,008,378 $900,688,845 +$32,135,922 $23.7 161
2020 Q4 37,131,836 $744,007,768 -$8,934,464 $20.03 135
2020 Q3 39,011,062 $812,260,717 +$4,160,811 $20.82 140
2020 Q2 37,020,602 $647,728,854 +$3,968,987 $17.5 149
2020 Q1 36,901,564 $602,550,993 +$85,027,216 $16.33 157
2019 Q4 31,512,474 $648,599,114 +$50,675,226 $20.58 134
2019 Q3 30,030,196 $344,731,286 -$4,710,643 $11.48 116
2019 Q2 30,820,855 $405,253,075 -$9,461,407 $13.15 127
2019 Q1 31,440,940 $476,061,688 -$37,383,003 $15.14 142
2018 Q4 33,763,313 $579,232,154 +$15,811,423 $17.17 119
2018 Q3 33,465,415 $491,620,289 +$14,683,142 $14.74 122
2018 Q2 31,032,309 $740,054,845 +$15,772,890 $23.85 131
2018 Q1 30,253,700 $772,956,896 +$49,280,895 $25.55 135
2017 Q4 28,485,885 $526,126,077 +$70,690,864 $18.46 99
2017 Q3 26,039,739 $273,144,788 +$14,140,125 $10.49 74
2017 Q2 24,547,432 $307,092,409 +$19,595,869 $12.51 69
2017 Q1 23,352,469 $234,899,241 +$9,397,867 $10.06 80
2016 Q4 23,305,863 $362,917,530 +$115,650,426 $15.57 86
2016 Q3 15,869,884 $305,753,967 +$28,932,707 $19.26 71
2016 Q2 14,623,227 $173,348,652 -$11,495,754 $11.85 73
2016 Q1 14,863,823 $269,759,000 +$54,374,659 $18.15 70
2015 Q4 11,882,728 $326,630,223 -$5,739,748 $27.5 58
2015 Q3 10,244,867 $226,510,468 +$24,645,746 $22.11 45
2015 Q2 9,280,769 $165,466,756 +$165,466,759 $17.84 45